The exercise period of TO3 starts today.
As part of our financing strategy and the agreement with L1 Capital, Brighter has distributed free warrants to the company's shareholders to reduce dilution. October 11 to October 25, 2018 is exercise period of Brighter Warrants TO3 during which holders of Warrants can subscribe for shares. The subscription price for the shares is SEK 4.
Holders of warrants who have their Warrants registered in custody at a bank or fund commissioner shall contact their bank or fund commissioner if they want to exercise the Warrants and subscribe for the corresponding shares. Exercise of the Warrants and subscription of shares for other holders of Warrants takes place through simultaneous payment and submittal of the registered application form, signed and submitted to the Company’s share agent no later than 16:00 CET on October 25, 2018.
The Company’s share agent is Eminova Fondkommission, which can be contacted by phone at 08-684 211 00 or by email at email@example.com. For terms and conditions of the Warrants, please visit Brighter’s website: https://brighter.se/investors/financing.
For further information, please contact:
Truls Sjöstedt, CEO
Telefon: +46 709 73 46 00
Ann Zetterberg, CFO
Tel: +46 708 37 21 23
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop®- is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. www.brighter.se
The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, firstname.lastname@example.org, www.eminova.se.